Chatgpt doesn't learn from user data, response was based on what ever it learned/trained in 2023.
As of my last update in 2023, Anavex Life Sciences has been conducting clinical trials for their drug candidate, Anavex 2-73 (blarcamesine), targeting Alzheimer's disease (AD) and other neurological disorders. The results from these trials have garnered attention and mixed reactions.
Market Data 
Markets 
AI
